Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oscar Health Inc (OSCR) vs Prospect Capital Corporation (PSEC) Price & Performance

Oscar Health IncTrade
Prospect Capital CorporationTrade

Price performance (Past 24H)

Key statistics

Oscar Health Inc vs Prospect Capital Corporation — how do they compare? Oscar Health Inc trades at $28.84 (market cap $9.28B), while Prospect Capital Corporation trades at $2.14 (market cap $1.08B). The key difference: Oscar Health Inc is far larger — about 8.6× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays a 23.26% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.

OSCRPSEC
Market Cap
$9.28B$1.08B
Sector
HealthFinancials
52-Week High
$32.18$3.47
52-Week Low
$10.85$2.15
Enterprise Value
$4.90B
Dividend Yield
23.26%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oscar Health Inc

Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.

The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.

Prospect Capital Corporation

Prospect Capital Corporation (PSEC) trades at $2.15, down 4.44% on the day, reflecting persistent bearish technical signals. The company's fundamentals are challenged, with negative revenue of -$407M and a net income margin of -495.94% for 2025, though it has beaten EPS estimates for the last three consecutive quarters. Recent corporate actions include regular dividend payments, while news highlights portfolio activity and deep discounts to net asset value.

The outlook remains cautious due to weak profitability and a bearish analyst consensus. The primary opportunity lies in the stock's high yield and significant discount to book value, but risks include ongoing revenue volatility, declining net asset value, and skepticism about portfolio quality. Investors should weigh income potential against fundamental deterioration.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR

About Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

Read more on PSEC